Furthermore, although our results show that asthma risk may be conferred by this locus to T2-low subjects, who would otherwise exhibit low FOXA3 levels, they suggest that minimal risk is conferred to T2-high subjects, who typically reach risk-conferring levels of FOXA3 by virtue of T2 inflammation alone. This evidence concerns the gene FOXA3 and asthma.